PPD

OCTOBER 12, 2023

Emerging areas of pharmaceutical research not only bring novel opportunities but also new regulatory guidance. DOWNLOAD OUR WHITE PAPER Learn more about how PPD® Laboratory services can enhance your CGT projects. The post Informed Design of Bioanalytical PCR Assay Testing Parameters appeared first on PPD Inc.

Laboratories 52

Laboratories Protein Expression Clinical Trials Pharmacokinetics 52

Conversations in Drug Development Trends

MARCH 7, 2024

When conducting first-in-human (FIH) clinical trials, small to midsize pharmaceutical and biotechnology companies are faced with several crucial choices that can shape the trajectory of their drug development pathway. For additional insights, download our full white paper, “ First-in-Human Studies: IND or CTA? ”.

Clinical Trials 52

Clinical Trials Trials FDA Drug Development 52

The Pharma Data

OCTOBER 23, 2020

23, 2020 — In a Society for Healthcare Epidemiology of America white paper, published online Oct. ” Several authors disclosed financial ties to the pharmaceutical and health care industries. Professional. SHEA Updates Guidance for Health Care Staff With Hepatitis, HIV. FRIDAY, Oct. Abstract/Full Text.

RNA 52

RNA Virus Vaccine Hospitals 52

H1 Blog

NOVEMBER 15, 2023

Since KOLs play such a critical role, engaging with the right KOLs is a key strategy for pharmaceutical companies to stay ahead of the game. Compliance ensures that interactions between pharmaceutical companies and KOLs are transparent, fair, and free from any undue influence.

Compliance 59

Compliance Science Regulations Pharmaceutical Companies 59

The Pharma Data

MARCH 31, 2022

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the launch of Save Legs. About the Janssen Pharmaceutical Companies of Johnson & Johnson. Change Lives. ™, Janssen seeks to elevate PAD research, collaboration, education and screening for communities placed at increased risk of cardiovascular disease.

Disease 52

Disease Pharmaceutical Companies Pharmaceuticals Research 52

Drug Discovery World

SEPTEMBER 29, 2022

In this listicle, SAMDITech outlines the benefits of outsourcing models in the pharmaceutical industry, looking past perceived costs to the value outsourcing can bring. . Challenges in outsourcing drug discovery. The goal of drug discovery is clear: Identify the most promising leads in the shortest amount of time.

Small Molecule 130

Small Molecule Assay Development DNA Biochemical Assays 130

The Pharma Data

JULY 28, 2021

Teva Pharmaceutical Industries Ltd. On behalf of clients, MGA conducts original data analysis, constructs economic models, conducts research, writes white papers and expert reports and offers strategic advice. Teva saved the United States $28.8 billion in 2020, $4.2 Source link: [link].

Marketing 52

Marketing Biosimilars Pharmaceuticals Drugs 52

The Pharma Data

NOVEMBER 20, 2020

Agility requires much tighter and more transparent holistic relationships with suppliers and levels of collaboration that have not been consistently achieved in the pharmaceutical industry, largely because of the constraints in sharing accurate data.”.

Pharma Companies 52

Pharma Companies Vaccine Pharmacy Drugs 52

The Pharma Data

DECEMBER 28, 2020

Our new directors are well-recognized for their leadership and accomplishments in the biopharmaceutical, biotechnology and pharmaceutical industries, as well as in public capital markets and corporate governance.” Russell served as a director of Endocyte, a Nasdaq-listed public company acquired by Novartis, and AMAG Pharmaceuticals.

Pharmaceuticals 52

Pharmaceuticals Government Pharmaceutical Companies Therapies 52

The Pharma Data

JANUARY 5, 2021

… Alcami’s scientists have substantial experience designing and executing food studies that comply with the highest quality standards, which have expedited formulation selection and regulatory approval for a variety of pharmaceutical dosage forms. Why are Food Studies needed?

Pharmaceuticals 52

Pharmaceuticals Disease 52

The Pharma Data

JANUARY 6, 2021

… Biopharmaceutical products represent up to 20 percent of the total pharmaceutical market and are growing at a rate of nearly eight percent annually. . DOWNLOAD TO LEARN MORE>>>> Source link.

Pharmaceuticals 52

Pharmaceuticals Production Marketing 52

The Pharma Data

DECEMBER 17, 2020

The analysis of metals in pharmaceutical actives (API), raw material, and drug products has changed as well. Today’s technology has not only changed the way we receive information, but has continually adapted and progressed how we acquire information. ICP-MS/OES has emerged as a critical analytical platform for this analysis.

Compliance 52

Compliance Production Pharmaceuticals Drugs 52

The Pharma Data

JANUARY 7, 2021

The pharmaceutical product landscape is rapidly and fundamentally changing with profound impact on research and development strategy and technology needs. Emerging Technology Needs and Value Proposition for Strategic Partnerships with Contract Development and Manufacturing Organizations (CDMOs).

Production 52

Production FDA Pharmaceuticals Marketing 52

Conversations in Drug Development Trends

APRIL 4, 2024

Developing pharmaceuticals is a complex process, requiring stringent bioanalytical method validation guidelines to ensure drug safety and efficacy. To help integrate these various regulatory standards, the International Council for Harmonization (ICH) of Technical Requirements for Pharmaceuticals for Human Use was founded in 2016.

Small Molecule 80

Small Molecule Clinical Trials Pharmaceuticals International 80

The Pharma Data

NOVEMBER 16, 2020

Download Pharma IQ ’s report in collaboration with Dotmatics and BioBright to explore why pharmaceutical data integrity and data security are more important than ever in the life sciences industry. Learn how to improve your data integrity and data security through automation. Download Your Copy.

Science 52

Science Production Pharmaceuticals Marketing 52

Agency IQ

NOVEMBER 10, 2023

BY ALEXANDER GAFFNEY, MS, RAC | NOV 9, 2023 6:35 PM CST Background on CDER’s Office of Pharmaceutical Quality (OPQ) CDER’s Office of Pharmaceutical Quality became operational in January 2015, making it a still relatively recent addition to the agency. Read AgencyIQ’s analysis of FDA’s QMM White Paper here.]

Pharmaceuticals 40

Pharmaceuticals Small Molecule Science FDA 40

The Pharma Data

MARCH 20, 2021

Fermentation is used in the production of renewable feedstocks for food products and ingredients, beverages, pharmaceutical compounds, nutraceuticals, through to fine and bulk chemicals. The Kluyver Center applies microbial genomics to improve the performance of microorganisms in industrial fermentation processes.

Bioinformatics 52

Bioinformatics Laboratories Production Engineering 52

Agency IQ

JULY 7, 2023

What is the state of pharmaceutical quality in the U.S.? Call it murky A new report published by the FDA’s Office of Pharmaceutical Quality (OPQ) promises a look at the current “State of Pharmaceutical Quality.” Read AgencyIQ’s analysis of FDA’s QMM White Paper here.]

Pharmaceuticals 40

Pharmaceuticals Science FDA Production 40

PPD

DECEMBER 19, 2023

While the FSP model is growing in popularity and serves a critical role in pharmaceutical development, getting the most out of this model requires dedicated roles to drive implementation, communications and planning. Read our white paper to learn the keys to successfully implementing functional service partnerships.

International 52

International Research Pharmaceuticals Drug Development 52

PPD

JULY 9, 2024

How the flex hub model saves one developer time and money As an example of the value that our flex hub model brings to biotech and pharmaceutical developers, here is a brief look at one long-term partnership in place since 2013. Ready to implement an FSP engagement as the ideal solution for all your lifecycle maintenance requirements?

Compliance 52

Compliance Production Clinical Research Marketing 52

Eye on FDA

NOVEMBER 18, 2021

Media coverage regarding the nomination has been largely focused on concerns expressed by some about Dr. Califf’s past work with pharmaceutical companies in clinical research. The reasoning is again based on Dr. Califf’s association with the pharmaceutical industry – an objection that seems less sure-footed this time around.

FDA 57

FDA Pharmaceuticals Pharmaceutical Companies Clinical Research 57

The Pharma Data

MARCH 20, 2021

attention both from the public and the pharmaceutical industry, it is important to recognize concurrent. The lab’s goal is the. use and development of proteomic methods to. study RNA virus replication and virus-host interactions and in particular the use of single-cell proteomics to aid in this research. As the race for an. therapeutics.

Laboratories 52

Laboratories Virus RNA Bioinformatics 52

FDA Law Blog: Biosimilars

JANUARY 24, 2024

is identified as “Improving Supply Chains for Critical Drugs,” and states: “ In 5 years, deploy broad synthetic biology and biomanufacturing capabilities to produce at least 25% of all active pharmaceutical ingredients (APIs) for small molecule drugs ” (emphasis added). generic pharmaceutical industry, resulting in low profit-margins.

Small Molecule 69

Small Molecule Government Production Pharmaceuticals 69

Agency IQ

FEBRUARY 21, 2024

As other health authorities started to require data standards, some, such as Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) and China’s National Medical Products Administration (NMPA) decided to opt for CDISC for regulatory submissions.

Science 40

Science Regulations International FDA 40

Drug & Device Law

JULY 31, 2023

It’s an interesting topic; Eric recently wrote a paper on it , and Bexis is putting together a “white paper” for the Product Liability Advisory Council on the same subject. Medicis Pharmaceutical Corp. , vs. Ortho-McNeil-Janssen Pharmaceuticals , 2013 WL 2917651 (Pa. Paddock Pool Construction Co. , Accord Kreves v.

Production 52

Production International Trials Government 52